In the present study, we assessed the effect of TIGAR KO on cardiac metabolism, pathological hypertrophy, and cardiac dysfunction in Ang-II-induced hypertension and showed that Ang-II decreased the expression of PFK-1 and Glut-4 in association with moderate cardiac hypertrophy, which was attenuated by the ablation of TIGAR. The gene discussed is SLC2A4; the disease is hypertensive disorder.